Delivery Order SPE2DB20D1004-SPE2DB24FF3M7
- Not listed
- This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The 12-month, firm fixed price contract, valued at $5,886.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This federal contract award is for the delivery of Advair HFA 45-21 MCG inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2024, with a completion date of February 8, 2024. The contract has a ceiling value of $1,335.71 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler, 12GM to the Defense Logistics Agency (DLA). The contract, valued at $1,561.98, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order with a firm fixed price and a completion date of January 30, 2024. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,624.51 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $10,470.61 and is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The contract has a potential value of $4,245.90 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award,...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The $9,604.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a completion date of May 7, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
- This federal contract award is for the delivery of Advair HFA 230-21 mcg inhaler (12 gram) to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $4,137.12 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp is an...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $5,776.91 and is a Firm Fixed Price Delivery Order with an ultimate completion date of May 7, 2024. The contract was awarded on May 6, 2024 and does not have a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhaler, a specialty pharmaceutical product. The $2,099.79 contract has a completion date of February 14, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of the company's...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF3M7Delivery Order
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers for the Defense Logistics Agency (DLA). The contract, valued at $2,672.20, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of February 5, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/2/24 |